QNCX
Quince Therapeutics, Inc.
31.00$
+3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +1.2% | +0.0% | -3.4% | -54.8% | +121.1% | -52.4% | +5.0% | -59.5% | -94.1% | – | – | – | -85.5% | +95.5% | -81.4% | +100.0% | +9.4% | +2.9% | – | – | +163,788.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.3% | +0.2% | +35.2% | +55.8% | +47.3% | +16.1% | +21.5% | +43.4% | -2.0% | +20.6% | -6.6% | +6.1% | -12.5% | -4.6% | +8.4% | -16.1% | -43.6% | -66.0% | +12.9% | +16.7% | -58.1% | +5.8% | +140.0% | +7.8% | +12.0% | +18.5% | +18.5% | +39.8% | -19.5% | +23.3% | +55.9% | -45.7% | -20.2% | – | |
| – | +2.9% | +63.6% | +27.7% | +67.6% | +97.3% | -6.1% | +26.2% | +19.0% | +20.3% | +17.8% | +1.3% | +29.9% | +8.9% | +8.1% | +9.1% | +9.3% | -0.5% | -52.0% | -18.3% | +7.7% | +10.6% | +10.2% | +5.3% | +1.3% | -5.6% | -22.7% | +18.0% | +11.8% | -30.2% | -1.8% | +10.8% | +17.4% | +289.6% | – | |
| – | -4.2% | +8.7% | +33.7% | +58.1% | +57.6% | +10.4% | +22.5% | +37.9% | +2.3% | +19.9% | -4.8% | +11.8% | -6.6% | -0.5% | +8.6% | -7.1% | -25.6% | -53.1% | -17.1% | +105.0% | -56.9% | +9.1% | +36.9% | +34.5% | +151.3% | -79.2% | +72.1% | +47.2% | -33.6% | +36.2% | +20.9% | -31.8% | +620.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -40.2% | -1.4% | +5.4% | +5.9% | +30.2% | +38.6% | -19.8% | +19.6% | -3.4% | -38.4% | -26.8% | -23.6% | -87.2% | +0.0% | +228,869.0% | -99.9% | +101.4% | +107.6% | +23.6% | +22.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -346.7% | – | |
| – | -24.6% | -175.9% | – | – | – | – | – | – | – | – | – | – | – | – | +228,869.0% | -100.3% | – | – | -5.6% | -187.3% | – | – | – | – | +16.1% | -63.9% | -46.2% | +571.4% | +42.6% | -168.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -310.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -346.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.